Correlation Between Tonix Pharmaceuticals and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Akari Therapeutics PLC, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Akari Therapeutics.
Diversification Opportunities for Tonix Pharmaceuticals and Akari Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Tonix and Akari is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Tonix Pharmaceuticals and Akari Therapeutics
Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to under-perform the Akari Therapeutics. In addition to that, Tonix Pharmaceuticals is 1.28 times more volatile than Akari Therapeutics PLC. It trades about -0.11 of its total potential returns per unit of risk. Akari Therapeutics PLC is currently generating about -0.04 per unit of volatility. If you would invest 1,060 in Akari Therapeutics PLC on August 29, 2024 and sell it today you would lose (948.00) from holding Akari Therapeutics PLC or give up 89.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Tonix Pharmaceuticals Holding vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Tonix Pharmaceuticals |
| Akari Therapeutics PLC |
Tonix Pharmaceuticals and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tonix Pharmaceuticals and Akari Therapeutics
The main advantage of trading using opposite Tonix Pharmaceuticals and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Tonix Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Tonix Pharmaceuticals vs. Palisade Bio | Tonix Pharmaceuticals vs. Ibio Inc | Tonix Pharmaceuticals vs. Jaguar Animal Health |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |